Based on these observations, the authors concluded that RSV might facilitate cellular DOX uptake through the downregulation of MRP1 and that RSV may help to overcome DOX resistance or sensitize AML cells resistant to doxorubicin (Fenig et al., 2004; Gupta et al., 2011). This evidence concerns the gene ABCC1 and acute myeloid leukemia.